Tag: ENROUTE

Silk Road to evaluate TCAR in standard surgical risk patients with...

Silk Road Medical today announced a post-market study to evaluate the transcarotid artery revascularisation (TCAR) system in the treatment of standard surgical risk patients...

Silk Road Medical announces US$47 million financing

Silk Road Medical has received US$47 million in new funding led by new investors Norwest Venture Partners and funds managed by Janus Capital Management...